SCYNEXIS INC — Director's Dealing 2018

Mar 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SCYNEXIS INC (SCYX)
CIK: 0001178253
Period of Report: 2018-03-08

Reporting Person: Angulo Gonzalez David (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-08	Common Stock	P	14790	$1.69	Acquired	88790	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-08	Common Stock Warrant (right to buy)	$1.85	P	11092	Acquired	2019-03-14	Common Stock (11092)	Direct
2018-03-08	Common Stock Warrant (right to buy)	$2.00	P	6655	Acquired	2023-03-08	Common Stock (6655)	Direct

Footnotes

F1: Reflects the purchase on March 8, 2018, of 14,790 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant).